Offer - Urjas Oil for just ₹ 1
Podobact CV 100 /62.5 Tablet is a prescription medicine that is available as a Tablet. Other than this, Podobact CV 100 /62.5 Tablet has some other therapeutic uses, which have been discussed ahead.
The right dosage of Podobact CV 100 /62.5 Tablet depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
While these are the most often observed Podobact CV 100 /62.5 Tablet side effects, there are can be others also. These have been listed below. Normally, these side effects of Podobact CV 100 /62.5 Tablet are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Podobact CV 100 /62.5 Tablet is Mild for pregnant women and Moderate for women who are breastfeeding. Warnings related to Podobact CV 100 /62.5 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Podobact CV 100 /62.5 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Jaundice are examples of such conditions. Some other conditions that can be affected by Podobact CV 100 /62.5 Tablet are listed in the contraindications section below.
Drug reaction of Podobact CV 100 /62.5 Tablet with other medicines has been reported. See below for a complete list.
You should also be aware that Podobact CV 100 /62.5 Tablet is safe while driving, and is addiction.
Podobact CV 100 /62.5 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| Adult |
|
| Geriatric |
|
Is the use of Podobact CV 100 /62.5 Tablet safe for pregnant women?
Pregnant women may get mild side effects from Podobact Cv.
Is the use of Podobact CV 100 /62.5 Tablet safe during breastfeeding?
Breastfeeding women may feel side effects of Podobact Cv. If you see any side effects, stop taking Podobact Cv immediately and talk to your doctor. Take Podobact Cv again, only after your doctor's advice.
What is the effect of Podobact CV 100 /62.5 Tablet on the Kidneys?
There can be some harmful effects on your kidneys after taking Podobact Cv. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Podobact CV 100 /62.5 Tablet on the Liver?
The liver can be affected by Podobact Cv. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Podobact Cv only after medical advice.
What is the effect of Podobact CV 100 /62.5 Tablet on the Heart?
Very few cases of side effects of Podobact Cv on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Podobact CV 100 /62.5 Tablet unless your doctor advises you to do so -
Is this Podobact CV 100 /62.5 Tablet habit forming or addictive?
No, there is no any evidence that Podobact CV 100 /62.5 Tablet is addictive.
Interaction between Food and Podobact CV 100 /62.5 Tablet
Taking Podobact CV 100 /62.5 Tablet with food does not cause any problems.
Interaction between Alcohol and Podobact CV 100 /62.5 Tablet
Information about the interaction of Podobact CV 100 /62.5 Tablet and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vantin® (cefpodoxime proxetil )
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311
